Clinical Characteristics and Inflammatory Immune Responses in COVID-19 Patients With Hypertension: A Retrospective

Chaoran Wu1, Guangbo Qu2, Lei Wang1

  • 1Department of Cardiology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.

Frontiers in Pharmacology
|November 11, 2021
PubMed

Insights

Hypertension increases COVID-19 severity and organ damage. However, long-term use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) may mitigate these risks in hypertensive COVID-19 patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cardiovascular and metabolic disorders increase COVID-19 severity and mortality.
  • The impact of hypertension and related medications (ACEI/ARB) on COVID-19 clinical outcomes remains unclear.

Purpose of the Study:

  • To investigate the clinical characteristics and inflammatory responses in COVID-19 patients with hypertension.
  • To evaluate the association between hypertension, ACEI/ARB use, and COVID-19 severity.

Main Methods:

  • 90 COVID-19 patients were categorized into hypertension and non-hypertension groups.
  • Hypertensive patients were further classified by blood pressure control and ACEI/ARB use.
  • Clinical data and inflammatory biomarkers were compared across groups.

Main Results:

  • Hypertensive patients showed higher AST and hs-cTnI levels.
  • Long-term ACEI/ARB use was associated with lower AST, LDL-C, white blood cell count, and inflammatory markers (though not always statistically significant).
  • Hypertensive COVID-19 patients not on ACEI/ARB had a significantly higher risk of severe disease.

Conclusions:

  • Hypertension can lead to organ damage in COVID-19 patients.
  • Long-term ACEI/ARB treatment may offer protective benefits against COVID-19 severity and organ injury in hypertensive individuals.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
89
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
159
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
159
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
107
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
322